Literature DB >> 25772979

Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray.

R N Heydarov1, E E Fesenko, B L Shaskolskiy, S A Klotchenko, A V Vasin, S V Titov, E I Dementieva, A S Zasedatelev, V M Mikhailovich, O I Kiselev.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25772979     DOI: 10.1134/S1607672915010032

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  11 in total

1.  Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.

Authors:  R C Buxton; B Edwards; R R Juo; J C Voyta; M Tisdale; R C Bethell
Journal:  Anal Biochem       Date:  2000-05-01       Impact factor: 3.365

2.  Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.

Authors:  A I Klimov; E Rocha; F G Hayden; P A Shult; L F Roumillat; N J Cox
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

3.  Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.

Authors:  Musa Hindiyeh; Daniela Ram; Michal Mandelboim; Tal Meningher; Shira Hirsh; Jana Robinov; Virginia Levy; Sara Orzitzer; Roberto Azar; Zehava Grossman; Ella Mendelson
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

4.  Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.

Authors:  R B Belshe; M H Smith; C B Hall; R Betts; A J Hay
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

Authors:  Varough M Deyde; Xiyan Xu; Rick A Bright; Michael Shaw; Catherine B Smith; Ye Zhang; Yuelong Shu; Larisa V Gubareva; Nancy J Cox; Alexander I Klimov
Journal:  J Infect Dis       Date:  2007-06-07       Impact factor: 5.226

6.  Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Authors:  Iain Stephenson; Jane Democratis; Angie Lackenby; Teresa McNally; James Smith; Manish Pareek; Joanna Ellis; Alison Bermingham; Karl Nicholson; Maria Zambon
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

7.  Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data.

Authors:  Jennifer M Laplante; Steven A Marshall; Matthew Shudt; Tam T Van; Erik S Reisdorf; Lisa A Mingle; Peter A Shult; Kirsten St George
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

8.  Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.

Authors:  Varough M Deyde; Tung Nguyen; Rick A Bright; Amanda Balish; Bo Shu; Stephen Lindstrom; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2009-01-05       Impact factor: 5.191

9.  New low-viscosity overlay medium for viral plaque assays.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Wolfgang Garten; Hans-Dieter Klenk
Journal:  Virol J       Date:  2006-08-31       Impact factor: 4.099

10.  Oligonucleotide microchip for subtyping of influenza A virus.

Authors:  Eugeny E Fesenko; Dmitry E Kireyev; Dmitry A Gryadunov; Vladimir M Mikhailovich; Tatyana V Grebennikova; Dmitry K L'vov; Alexander S Zasedatelev
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.